Pulmonary vascular remodeling and increased arterial wall stiffness are two major causes for the elevated pulmonary vascular resistance and pulmonary arterial pressure in patients and animals with pulmonary hypertension. Cellular copper (Cu) plays an important role in angiogenesis and extracellular matrix remodeling; increased Cu in vascular smooth muscle cells has been demonstrated to be associated with atherosclerosis and hypertension in animal experiments. In this study, we show that the Cu-uptake transporter 1, CTR1, and the Cu-efflux pump, ATP7A, were both upregulated in the lung tissues and pulmonary arteries of mice with hypoxia-induced pulmonary hypertension. Hypoxia also significantly increased expression and activity of lysyl oxidase (LOX), a Cu-dependent enzyme that causes crosslinks of collagen and elastin in the extracellular matrix. In vitro experiments show that exposure to hypoxia or treatment with cobalt (CoCl2) also increased protein expression of CTR1, ATP7A, and LOX in pulmonary arterial smooth muscle cells (PASMC). In PASMC exposed to hypoxia or treated with CoCl2, we also confirmed that the Cu transport is increased using 64Cu uptake assays. Furthermore, hypoxia increased both cell migration and proliferation in a Cu-dependent manner. Downregulation of hypoxia-inducible factor 1α (HIF-1α) with siRNA significantly attenuated hypoxia-mediated upregulation of CTR1 mRNA. In summary, the data from this study indicate that increased Cu transportation due to upregulated CTR1 and ATP7A in pulmonary arteries and PASMC contributes to the development of hypoxia-induced pulmonary hypertension. The increased Cu uptake and elevated ATP7A also facilitate the increase in LOX activity and thus the increase in crosslink of extracellular matrix, and eventually leading to the increase in pulmonary arterial stiffness.
Stamm JA, Risbano MG, Mathier MA (2011) Overview of current therapeutic approaches for pulmonary hypertension. Pulm Circ 1: 138–159. doi: 10.4103/2045-8932.83444
[3]
Wang Z, Chesler NC (2011) Pulmonary vascular wall stiffness: An important contributor to the increased right ventricular afterload with pulmonary hypertension. Pulm Circ 1: 212–223. doi: 10.4103/2045-8932.83453
[4]
Durmowicz AG, Stenmark KR (1999) Mechanisms of structural remodeling in chronic pulmonary hypertension. Pediatr Rev 20: e91–e102.
[5]
van Suylen RJ, Smits JF, Daemen MJ (1998) Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension. Am J Respir Crit Care Med 157: 1423–1428. doi: 10.1164/ajrccm.157.5.9709050
[6]
Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, et al. (2009) Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 54: S20–31. doi: 10.1016/j.jacc.2009.04.018
[7]
Pak O, Aldashev A, Welsh D, Peacock A (2007) The effects of hypoxia on the cells of the pulmonary vasculature. Eur Respir J 30: 364–372. doi: 10.1183/09031936.00128706
[8]
Tian L, Chesler NC (2012) In vivo and in vitro measurements of pulmonary arterial stiffness: A brief review. Pulm Circ 2: 505–517. doi: 10.4103/2045-8932.105040
Malenfant S, Neyron AS, Paulin R, Potus F, Meloche J, et al. (2013) Signal transduction in the development of pulmonary arterial hypertension. Pulm Circ 3: 278–293. doi: 10.4103/2045-8932.114752
[11]
Turski ML, Thiele DJ (2009) New roles for copper metabolism in cell proliferation, signaling, and disease. J Biol Chem 284: 717–721. doi: 10.1074/jbc.r800055200
[12]
Kaplan JH, Lutsenko S (2009) Copper transport in mammalian cells: special care for a metal with special needs. J Biol Chem 284: 25461–25465. doi: 10.1074/jbc.r109.031286
[13]
Cross JB, Currier RP, Torraco DJ, Vanderberg LA, Wagner GL, et al. (2003) Killing of bacillus spores by aqueous dissolved oxygen, ascorbic acid, and copper ions. Appl Environ Microbiol 69: 2245–2252. doi: 10.1128/aem.69.4.2245-2252.2003
[14]
Gaetke LM, Chow CK (2003) Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology 189: 147–163. doi: 10.1016/s0300-483x(03)00159-8
[15]
Durand MJ, Lombard JH (2013) Low-dose angiotensin II infusion restores vascular function in cerebral arteries of high salt-fed rats by increasing copper/zinc superoxide dimutase expression. Am J Hypertens 26: 739–747.
[16]
Gabrielli LA, Castro PF, Godoy I, Mellado R, Bourge RC, et al. (2011) Systemic oxidative stress and endothelial dysfunction is associated with an attenuated acute vascular response to inhaled prostanoid in pulmonary artery hypertension patients. J Card Fail 17: 1012–1017. doi: 10.1016/j.cardfail.2011.08.008
[17]
Schaefer M, Gitlin JD (1999) Genetic disorders of membrane transport. IV. Wilson's disease and Menkes disease. Am J Physiol 276: G311–314.
[18]
Rucker RB, Romero-Chapman N, Wong T, Lee J, Steinberg FM, et al. (1996) Modulation of lysyl oxidase by dietary copper in rats. J Nutr 126: 51–60.
[19]
Eisses JF, Kaplan JH (2002) Molecular characterization of hCTR1, the human copper uptake protein. J Biol Chem 277: 29162–29171. doi: 10.1074/jbc.m203652200
[20]
Eisses JF, Stasser JP, Ralle M, Kaplan JH, Blackburn NJ (2000) Domains I and III of the human copper chaperone for superoxide dismutase interact via a cysteine-bridged Dicopper(I) cluster. Biochemistry 39: 7337–7342. doi: 10.1021/bi000690j
[21]
Kim BE, Nevitt T, Thiele DJ (2008) Mechanisms for copper acquisition, distribution and regulation. Nat Chem Biol 4: 176–185. doi: 10.1038/nchembio.72
[22]
Barnes N, Bartee MY, Braiterman L, Gupta A, Ustiyan V, et al. (2009) Cell-specific trafficking suggests a new role for renal ATP7B in the intracellular copper storage. Traffic 10: 767–779. doi: 10.1111/j.1600-0854.2009.00901.x
[23]
Linz R, Barnes NL, Zimnicka AM, Kaplan JH, Eipper B, et al. (2008) Intracellular targeting of copper-transporting ATPase ATP7A in a normal and ATP7B-/- kidney. Am J Physiol Renal Physiol 294: F53–61. doi: 10.1152/ajprenal.00314.2007
[24]
White C, Kambe T, Fulcher YG, Sachdev SW, Bush AI, et al. (2009) Copper transport into the secretory pathway is regulated by oxygen in macrophages. J Cell Sci 122: 1315–1321. doi: 10.1242/jcs.043216
[25]
Bogaard HJ, Mizuno S, Guignabert C, Al Hussaini AA, Farkas D, et al. (2012) Copper dependence of angioproliferation in pulmonary arterial hypertension in rats and humans. Am J Respir Cell Mol Biol 46: 582–591. doi: 10.1165/rcmb.2011-0296oc
[26]
Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, et al. (2006) Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440: 1222–1226. doi: 10.1038/nature04695
[27]
Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, et al. (2005) Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 115: 2811–2821. doi: 10.1172/jci24838
Hochachka PW, Buck LT, Doll CJ, Land SC (1996) Unifying theory of hypoxia tolerance: molecular/metabolic defense and rescue mechanisms for surviving oxygen lack. Proc Natl Acad Sci U S A 93: 9493–9498. doi: 10.1073/pnas.93.18.9493
[30]
Eisses JF, Chi Y, Kaplan JH (2005) Stable plasma membrane levels of hCTR1 mediate cellular copper uptake. J Biol Chem 280: 9635–9639. doi: 10.1074/jbc.m500116200
[31]
Yuan Y, Hilliard G, Ferguson T, Millhorn DE (2003) Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha. J Biol Chem 278: 15911–15916. doi: 10.1074/jbc.m300463200
[32]
Xie L, Collins JF (2011) Transcriptional regulation of the Menkes copper ATPase (ATP7A) gene by hypoxia-inducible factor (HIF-2alpha) in intestinal epithelial cells. Am J Physiol Cell Physiol 300: C1298–1305. doi: 10.1152/ajpcell.00023.2011
[33]
Molloy SA, Kaplan JH (2009) Copper-dependent recycling of hCTR1, the human high affinity copper transporter. J Biol Chem 284: 29704–29713. doi: 10.1074/jbc.m109.000166
[34]
Ashino T, Sudhahar V, Urao N, Oshikawa J, Chen GF, et al. (2010) Unexpected role of the copper transporter ATP7A in PDGF-induced vascular smooth muscle cell migration. Circ Res 107: 787–799. doi: 10.1161/circresaha.110.225334
[35]
Song M, Song Z, Barve S, Zhang J, Chen T, et al. (2008) Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis. J Pharmacol Exp Ther 325: 409–416. doi: 10.1124/jpet.107.131227
[36]
Rae TD, Schmidt PJ, Pufahl RA, Culotta VC, O'Halloran TV (1999) Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science 284: 805–808. doi: 10.1126/science.284.5415.805
[37]
Maryon EB, Molloy SA, Kaplan JH (2013) Cellular glutathione plays a key role in copper uptake mediated by human copper transporter 1. Am J Physiol Cell Physiol 304: C768–779. doi: 10.1152/ajpcell.00417.2012
[38]
Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, et al. (2009) Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139: 891–906. doi: 10.1016/j.cell.2009.10.027
[39]
Sun M, Northup N, Marga F, Huber T, Byfield FJ, et al. (2007) The effect of cellular cholesterol on membrane-cytoskeleton adhesion. J Cell Sci 120: 2223–2231. doi: 10.1242/jcs.001370
[40]
Shentu TP, Titushkin I, Singh DK, Gooch KJ, Subbaiah PV, et al. (2010) oxLDL-induced decrease in lipid order of membrane domains is inversely correlated with endothelial stiffness and network formation. Am J Physiol Cell Physiol 299: C218–229. doi: 10.1152/ajpcell.00383.2009
[41]
Byfield FJ, Tikku S, Rothblat GH, Gooch KJ, Levitan I (2006) OxLDL increases endothelial stiffness, force generation, and network formation. J Lipid Res 47: 715–723. doi: 10.1194/jlr.m500439-jlr200
[42]
Sato M, Theret DP, Wheeler LT, Ohshima N, Nerem RM (1990) Application of the micropipette technique to the measurement of cultured porcine aortic endothelial cell viscoelastic properties. J Biomech Eng 112: 263–268. doi: 10.1115/1.2891183
[43]
Oh MJ, Kuhr F, Byfield F, Levitan I (2012) Micropipette aspiration of substrate-attached cells to estimate cell stiffness. J Vis Exp.
[44]
Zhou B, Gitschier J (1997) hCTR1: a human gene for copper uptake identified by complementation in yeast. Proc Natl Acad Sci U S A 94: 7481–7486. doi: 10.1073/pnas.94.14.7481
[45]
Maryon EB, Molloy SA, Kaplan JH (2007) O-linked glycosylation at threonine 27 protects the copper transporter hCTR1 from proteolytic cleavage in mammalian cells. J Biol Chem 282: 20376–20387. doi: 10.1074/jbc.m701806200
[46]
De Feo CJ, Aller SG, Siluvai GS, Blackburn NJ, Unger VM (2009) Three-dimensional structure of the human copper transporter hCTR1. Proc Natl Acad Sci U S A 106: 4237–4242. doi: 10.1073/pnas.0810286106
[47]
White C, Lee J, Kambe T, Fritsche K, Petris MJ (2009) A role for the ATP7A copper-transporting ATPase in macrophage bactericidal activity. J Biol Chem 284: 33949–33956. doi: 10.1074/jbc.m109.070201
[48]
Patel SA, Simon MC (2008) Biology of hypoxia-inducible factor-2alpha in development and disease. Cell Death Differ 15: 628–634. doi: 10.1038/cdd.2008.17
[49]
Benita Y, Kikuchi H, Smith AD, Zhang MQ, Chung DC, et al. (2009) An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia. Nucleic Acids Res 37: 4587–4602. doi: 10.1093/nar/gkp425
[50]
Martin F, Linden T, Katschinski DM, Oehme F, Flamme I, et al. (2005) Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation. Blood 105: 4613–4619. doi: 10.1182/blood-2004-10-3980
[51]
Feng W, Ye F, Xue W, Zhou Z, Kang YJ (2009) Copper regulation of hypoxia-inducible factor-1 activity. Mol Pharmacol 75: 174–182. doi: 10.1124/mol.108.051516
[52]
Alcudia JF, Martinez-Gonzalez J, Guadall A, Gonzalez-Diez M, Badimon L, et al. (2008) Lysyl oxidase and endothelial dysfunction: mechanisms of lysyl oxidase down-regulation by pro-inflammatory cytokines. Front Biosci 13: 2721–2727. doi: 10.2741/2879
[53]
Rodriguez C, Martinez-Gonzalez J, Raposo B, Alcudia JF, Guadall A, et al. (2008) Regulation of lysyl oxidase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases. Cardiovasc Res 79: 7–13. doi: 10.1093/cvr/cvn102
[54]
Siddikuzzaman, Grace VM, Guruvayoorappan C (2011) Lysyl oxidase: a potential target for cancer therapy. Inflammopharmacology 19: 117–129. doi: 10.1007/s10787-010-0073-1
